Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13044167 | 1.00 | CTDSP1 (0.49) | CTDSP1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL9604158 | 1.00 | CTDSP1 (0.49) | CTDSP1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL9604156 | 1.00 | CTDSP1 (0.49) | CTDSP1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL9604154 | 1.00 | CTDSP1 (0.49) | CTDSP1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL9604159 | 1.00 | CTDSP1 (0.49) | CTDSP1KMT2AL3MBTL1GAAALDH1A1 | |
| SCHEMBL9604129 | 0.89 | CTDSP1 (0.40) | CTDSP1ALDH1A1LMNA | |
| SCHEMBL9604121 | 0.89 | CTDSP1 (0.40) | CTDSP1ALDH1A1LMNA | |
| SCHEMBL9604148 | 0.89 | CTDSP1 (0.40) | CTDSP1ALDH1A1LMNA | |
| SCHEMBL9604119 | 0.89 | CTDSP1 (0.40) | CTDSP1ALDH1A1LMNA | |
| SCHEMBL9604186 | 0.89 | CTDSP1 (0.40) | CTDSP1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157560-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120157560-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120136070-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120136070-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XL TERRA, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| WO-2010138842-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | XLTERRA, INC. (US) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136070-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | KHK, HKDC1, HK2 | CTDSP1 4006/4885KMT2A 1049/4885L3MBTL1 3268/4885 |
| US-20120157560-A1 | KETAL ESTERS OF ANHYDROPENTITOLS AND USES THEREOF | KHK, HKDC1, HK2 | CTDSP1 4006/4885KMT2A 1049/4885L3MBTL1 3268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.